Updated: Fri, 10/11/2024 - 12:00

Campus/building access, classes and work will return to usual conditions, as of Saturday, Oct. 12. See Campus Public Safety website for details.


Accès au campus et aux immeubles, cours et modalités de travail : retour à la normale à compter du samedi 12 octobre. Complément d’information : Direction de la protection et de la prévention.

Stem cells and the future of health care - The Globe and Mail, December 8, 2021

Published: 9 December 2021

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, participated in a Globe and Mail panel on stem cells. Learn more and watch the recording.

When To Stop Hoping For a COVID-19 Miracle Cure - FiveThirtyEight, August 4, 2021

Published: 5 August 2021

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit is among the experts quoted by FiveThirtyEight.

Experts: FDA approves much-debated Alzheimer's drug panned by experts

Published: 10 June 2021

U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...

Why the credibility of AstraZeneca's vaccine data matters - Yahoo News, March 24, 2021

Published: 25 March 2021

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit is among the experts quoted in this piece about the AstraZeneca vaccine....

Expert opinion: COVID-19 vaccine rollout unlikely before fall 2021

Published: 1 October 2020

Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published...

CTV NEWS | Hundreds of Canadians willing to be infected with coronavirus to speed vaccine research

Published: 19 May 2020

Thousands of healthy volunteers, including hundreds of Canadians, have offered to try getting injected with a potential vaccine and then purposely becoming infected with COVID-19 to test if the...

NATIONAL POST | Mom fears losing access to experimental drug that helped daughter after study ends

Published: 27 March 2018

Jonathan Kimmelman, director of biomedical ethics at McGill University, agreed companies have some obligation to continue to provide care for patients who take part in studies to test experimental...

Pages

Back to top